Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

stomach gastrointestinal digestive

MR elastography a useful gut-check for patients with inflammatory bowel disease

The pilot notched a 100% success rate and may ultimately help patients and doctors decide between medication and surgery.

Thumbnail

RSNA, other medical imaging groups launch brain tumor artificial intelligence challenge

Winners of the 10th annual Brain Tumor Segmentation challenge will be recognized at the AI Showcase Theater during RSNA 2021.

chest pain lung pulmonary embolism

Radiology directed mandates required to curb long-term overuse of CT for pulmonary embolisms

Hawaiian researchers found merely recommending providers utilize higher D-dimer requirements wasn't enough to decrease CTPA orders and increase positivity rates.

Thumbnail

New York researchers awarded $1.6M to enhance imaging-driven leg ulcer care

University at Buffalo experts will build upon photoacoustic tomography techniques and help doctors more quickly assess the results of leg surgeries.

fatty liver disease hepatic steatosis

Ultrasound is useful for assessing COVID-19 long-haulers, particularly liver problems

Multiparametric US uncovered signs of organ damage in post-COVID individuals and proved more accurate than MRI and CT for some indications, experts reported in the Journal of Ultrasound in Medicine.

FDA calls for investigation into Alzheimer’s drug; imaging group maintains amyloid PET is key

The Society of Nuclear Medicine & Molecular Imaging says such scans are key for diagnosing the disease and will be monitoring the administration's findings.

Thumbnail

Echocardiogram add-on predicts patients at risk of developing heart problems from COVID-19

Speckle-tracking strain is a safe, affordable way to gain clues into who may develop atrial fibrillation and require additional monitoring down the road.

FDA changes course, limiting suggested uses for groundbreaking Alzheimer’s drug

The agency now recommends Aduhelm only for patients in the early stages of the disease, more closely aligning with the population tested during clinical trials.

Around the web

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.